Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (3): 324-230.doi: 10.3736/jcim20080321

• Conference Summary • Previous Articles    

Report of the 10th Annual Meeting of the Chinese Society of Clinical Oncology

Zhi-cheng Cao()   

  1. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
  • Online:2008-03-20 Published:2008-03-15
  • Contact: WCS Cho E-mail:chocs@ha.org.hk

The 10th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) was held on 19-23 September 2007 in Harbin. The theme of this conference was "putting standard multidisciplinary cancer management into practice" and special reports of standard multidisciplinary management on various cancers were presented. Over 3 500 clinical oncologists and scientists participated in the 2007 CSCO Annual Meeting where more than ten international top experts were invited to exchange valuable experiences with the delegates. The programs consisted of Education Session, Satellite Symposium and Meet the Professor Session. The latest research results were presented as oral presentations and posters at the congress. Several hotspots were particularly highlighted in this report, including innovative radiotherapy and chemotherapy methods, researches on molecular targets and clinical trials of targeted therapy, such as endostatin, volociximab, cetuximab, bevacizumab and temozolomide. The remarkable research results of anti-cancer Chinese medicine, cancer screening and prognosis were also introduced. This article tries to call the attention to some hot topics in the program that are both new and noteworthy, and it may serve as a highlight of this important international cancer research meeting for clinical oncologists and scientists.

Key words: Chinese Society of Clinical Oncology, conferences, neoplasms, therapy, Chinese herbal drugs

CLC Number: 

  • R-27
[1] Xu XY, Hu SL, Lu S , et al. Clinical observations of three-dimensional conformal radiation therapy for non-small cell lung cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):56-57
徐向英, 胡松柳, 卢姗 , 等. 三维适形放疗治疗非小细胞肺癌的临床观察[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):56-57
[2] Wang JL, Li J, Liu TS , et al. A phase Ⅲ multi-center randomized controlled trial of raltitrexed versus 5-FU/CF combined with oxaliplatin in treating patients with advanced or relapse of colorectal cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):22-23
王佳蕾, 李进, 刘天舒 , 等. 雷替曲塞或5-FU/CF联合奥沙利铂治疗局部晚期或复发转移性结直肠癌多中心、随机、对照Ⅲ期临床试验[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):22-23
[3] Cui CL, Chi ZH, Yuan XQ , et al. A phase Ⅱ clinical trial of adoptive CIK cell transfer therapy following lymphodepleting chemotherapy for the treatment of patients with liver metastatic melanoma[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):62
崔传亮, 迟志宏, 袁香庆 , 等. 淋巴细胞删除性化疗联合自体CIK细胞回输治疗进展期黑色素瘤肝转移Ⅱ期临床研究[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):62
[4] Au JS, Cho WCS, Yip TT , et al. Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):5-6
区兆基, 曹志成, 叶大同 , 等. 蛋白质组学在香港非吸烟女性肺腺癌组织的肿瘤标志物研究中的应用[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):5-6
[5] Zhou QH.Progress in study of reversion in invasion and metastasis of lung cancer[J].CSCO Annual Meeting Education Book, 2007,: 259-264
周清华 .肺癌侵袭转移的逆转研究进展[J].CSCO年会教育专辑, 2007,: 259-264
[6] Wang K, Shen F, Shi LH , et al. Gene expression profile analysis in human hepatocellular carcinoma predicts the risk for metastasis using cDNA microarrays[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):16-17
王葵, 沈锋, 施乐华 , 等. 采用基因芯片筛选肝癌转移相关基因的研究[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):16-17
[7] Yu GZ, Chen Y, Pan J , et al. The construction of tissue microarrays of gastric carcinoma and analysis of clinicopathological prognostic factors of Chinese gastric cancer patients[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):24
于观贞, 陈颖, 潘军 , 等. 大规模胃癌组织芯片的构建以及胃癌预后因素的分析[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):24
[8] You CX, Su J, Liao WJ , et al. Experiment on BA46 gene transferring dendritic cells and application in the treatment of breast cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):45
尤长宣, 苏瑾, 廖旺军 , 等. 乳腺癌BA46基因转染树突状细胞诱导特异细胞免疫[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):45
[9] Lou RC, Yang Y, Cui Y .Heparanase and the microenvironment of tumor[J].CSCO Annual Meeting Education Book, 2007,: 570-574
罗荣城, 杨洋, 崔瑶 .类肝素酶与肿瘤微环境[J].CSCO年会教育专辑, 2007,: 570-574
[10] Li QL, Chen FJ . Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor[J]. Ai Zheng, 2002,21(6):696-700
doi: 10.3321/j.issn:1000-467X.2002.06.028
李秋梨, 陈福进 . 血管内皮生长因子-C、-D与肿瘤淋巴道转移研究进展[J]. 癌症, 2002,21(6):696-700
doi: 10.3321/j.issn:1000-467X.2002.06.028
[11] Wang JW, Sun Y, Liu YY , et al. Results of randomized, multicenter, double-blind phase Ⅲ trial of rh-endostatin(YH-16) in treatment of advanced non-small cell lung cancer patients[J]. Zhongguo Fei Ai Za Zhi, 2005,8(4):283-290
doi: 10.3779/cjlc.v8i4.1926
王金万, 孙燕, 刘永煜 , 等. 重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J]. 中国肺癌杂志, 2005,8(4):283-290
doi: 10.3779/cjlc.v8i4.1926
[12] Isagani C . Final results from cohort 1 of a phase 2 study of volociximab, an anti-a5b1 integrin monoclonal antibody, in patients with metastatic renal cell carcinoma[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):61-62
Isagani C. Volociximab治疗转移性肾细胞癌的疗效评价[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):61-62
[13] Shen L . Progress of targeted therapy for gastrointestinal stromal tumor[J]. Ai Zheng Jing Zhan, 2007,5(1):25-29
doi: 10.3969/j.issn.1672-1535.2007.01.008
沈琳 . 胃肠间质瘤的靶向治疗进展[J]. 癌症进展, 2007,5(1):25-29
doi: 10.3969/j.issn.1672-1535.2007.01.008
[14] Yung AW . Personalized cancer therapy: coming soon[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):330-331
[15] Cai YJ, Zheng DY, Luo RC , et al. Bevacizumab combined with cisplatin inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):47
蔡艳军, 郑大勇, 罗荣城 , 等. 贝伐单抗联合顺铂对VEGF高表达的荷卵巢癌裸鼠腹水的抑制作用[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):47
[16] Meng ZQ, Yang PY, Shen YH, et al. Preclinical evaluation and phase I study of cinobufotalin in cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO 年会专刊):60-61
Meng ZQ, Yang PY, Shen YH , et al. Preclinical evaluation and phase I study of cinobufotalin in cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):60-61
[17] Chen XZ, Shen QP, Tian HQ , et al. Constant infusion of cinobufotalin combined with chemotherapy for the treatment of middle/advanced lung cancer patients[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):333
陈学彰, 沈秋萍, 田华琴 , 等. 华蟾素恒速输注联合化疗治疗中晚期肺癌患者[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):333
[18] Deng J . Clinical observations of cinobufotalin combined with gefitinib for advanced non-small cell lung cancer patients[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):333
doi: 10.3969/j.issn.1673-9523.2007.11.016
邓俭 . 华蟾素联合吉非替尼治疗晚期非小细胞肺癌临床观察[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):333
doi: 10.3969/j.issn.1673-9523.2007.11.016
[19] Lin HS, Li DR . A multi-center randomized controlled trial of Shenqi Fuzheng Injection in improving the quality of life of non-small cell lung cancer patients treated with chemotherapy[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):2
林洪生, 李道睿 . 参芪扶正注射液提高非小细胞肺癌化疗患者生存质量的随机、对照、多中心临床试验[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):2
[20] Sun YF, Pei Y, Tian YX , et al. Observation of clinical effect of Shenqi Fuzheng Injection combined with chemotherapy in the treatment of advanced gastric cancer with qi deficiency[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):96-97
孙玉凤, 裴毅, 田迎霞 , 等. 参芪扶正注射液联合化疗治疗气虚型进展期胃癌病人疗效观察[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):96-97
[21] He Q, Guan YS, La Z , et al. Effect of Shenqi Fuzheng Injection on the adverse effects and quality of life of patients with hepatocellular carcinoma during intervention therapy[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):15
贺庆, 官泳松, 拉孜 , 等. 参芪扶正注射液对肝癌患者介入治疗期间毒副反应和生命质量的影响[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):15
[22] Liu J, Lin RH, Su Y , et al. Effect of new C21 steroidal glycosides on gastric cancer cell line SCG7901 treated by hyperthermic chemotherapy[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):93-94
刘健, 林如辉, 苏颖 , 等. 新C21甾体苷对胃癌SGC7901细胞株热化疗效果的影响[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):93-94
[23] Lin Q, Chen K, Zhao YX , et al. Effect of Aidi Injection on the short-term quality of life in patients with primary carcinoma receiving chemotherapy: A prospective randomized controlled study[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):58
蔺强, 陈坤, 赵艳勋 , 等. 艾迪注射液对恶性肿瘤患者近期生存质量影响的临床对照研究[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):58
[24] Pan YL, Pan ZY . Observation on the effect of Zhiling Capsule in treating 400 patients with various cancers of middle/advanced stage[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):58
doi: 10.3321/j.issn:1003-5370.2007.09.012
潘云苓, 潘志远 . 志苓胶囊治疗400例多种中晚期癌症的疗效观察[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):58
doi: 10.3321/j.issn:1003-5370.2007.09.012
[25] Yan ZC, Wu XZ, Sun HY , et al. Effect of Wenhua Capsule in the cell proliferation and cell cycle of human breast cancer cell line T-47D[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):59
doi: 10.7666/d.y880810
闫祝辰, 吴雄志, 孙海燕 , 等. 温化胶囊对人乳腺癌T-47D细胞增殖和细胞周期的影响[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):59
doi: 10.7666/d.y880810
[26] Sun H, Xue D, Gao F , et al. Results of a randomized double-blind clinical trial of Shugan Liangxue Prescription for relieving hot flashes in breast cancer patients[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):155
孙红, 薛冬, 高非 , 等. 中药舒肝凉血复方改善乳腺癌潮热的随机双盲临床研究[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):155
[27] Gao DL, Wang WW, Qian F , et al. Evaluation for intervention effect of breast self examination for decreasing breast cancer mortality[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):40
高道利, 王文婉, 钱锋 , 等. 乳腺癌的二级预防——上海26万妇女乳房自我检查效果的评估[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):40
[28] Li R, Yu GZ, Wang X , et al. Analysis of the effect of cancer-associated anemia and pathological condition on the survival period of patients with gastric cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):153
李睿, 于观贞, 王喜 , 等. 肿瘤相关贫血与胃癌病理状况对胃癌患者生存时间影响的相关分析[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):153
[29] Cho WC, Cheng CH . Oncoproteomics: current trends and future perspectives[J]. Expert Rev Proteomics, 2007,4(3):401-410
doi: 10.1016/j.jnucmat.2003.11.003 pmid: 17552924
[30] Cho WC.Contribution of oncoproteomics to cancer biomarker discovery[J]., 2007, 6(): 25
[31] Cho WC.OncomiRs: the discovery and progress of microRNAs in cancers[J].Mol Cancer, 2007, 6(): 60
[32] Cho WC . Application of proteinchip technologies in the diagnostics, classification, monitoring and prognostication of various cancers[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2007,( CSCO Annual Meeting Issue):157-158
曹志成 . 蛋白质芯片技术在癌症的诊断、分型、监察和预后的应用[J]. 临床肿瘤学杂志, 2007,( CSCO 年会专刊):157-158
[33] Wang LY, Tang ZQ, Feng FY . Practical control methods for the dose individualization of anticancer drugs[J]. Ai Zheng, 2002,21(12):1382-1385
王丽焱, 汤致强, 冯奉仪 . 抗肿瘤药物剂量个体化的实用控制方法[J]. 癌症, 2002,21(12):1382-1385
[34] Cho WC . Progress of treatment for bladder cancer[J]. Zhong Xi Yi Jie He Xue Bao, 2007,5(1):85-91
曹志成 . 膀胱癌治疗进展[J]. 中西医结合学报, 2007,5(1):85-91
[35] Cho WC, Leung KN . In vitro and in vivo anti-tumor effects of Astragalus membranaceus[J]. Cancer Lett, 2007,252(1):43-54
doi: 10.1016/j.canlet.2006.12.001 pmid: 17223259
[36] Cho WC . Integrated therapy and research progress in molecular therapy for intracranial tumor[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2007,27(7):1047-1051
曹志成 . 颅内肿瘤综合治疗及其分子治疗研究进展[J]. 南方医科大学学报, 2007,27(7):1047-1051
[37] Cho WC . Progress of integrative medicine, human papillomavirus vaccine and molecular targeted therapy for cervical cancer[J]. Zhong Xi Yi Jie He Xue Bao, 2008,6(2):203-208
曹志成 . 子宫颈癌的中西医诊疗概况和人类乳头瘤病毒疫苗及分子靶向研究进展[J]. 中西医结合学报, 2008,6(2):203-208
[1] Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283.
[2] Tara Rajendran, Martha Summa-Chadwick. The scope and potential of music therapy in stroke rehabilitation. Journal of Integrative Medicine, 2022, 20(4): 284-287.
[3] Lu Yin, Yun An, Xiao Chen, Hui-xin Yan, Tao Zhang, Xin-gang Lu, Jun-tao Yan. Local vibration therapy promotes the recovery of nerve function in rats with sciatic nerve injury. Journal of Integrative Medicine, 2022, 20(3): 265-273.
[4] Bin Zhao, Yong Chen, Shi-min Liao, Jian-ying Zheng, Shi-hua Yan, Dong-shu Zhang. Successfully treated recalcitrant atopic eczema with acupoint autohemotherapy: A case report and hypothesized mechanism of the therapy. Journal of Integrative Medicine, 2022, 20(2): 182-186.
[5] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[6] Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.
[7] Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.
[8] Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466.
[9] Zahra Karimzadeh, Mansooreh Azizzadeh Forouzi, Haleh Tajadini, Mehdi Ahmadinejad, Callista Roy, Mahlagha Dehghan. Effects of lavender and Citrus aurantium on pain of conscious intensive care unit patients: A parallel randomized placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(4): 333-339.
[10] Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[11] Riska Siregar, Aris Setyawan, Syahruramdhani Syahruramdhani. A model to standardize safety and quality of care for cupping therapy. Journal of Integrative Medicine, 2021, 19(4): 327-332.
[12] Bing-rong Li, Shi-yun Shao, Long Yuan, Ru Jia, Jian Sun, Qing Ji, Hua Sui, Li-hong Zhou, Yi Zhang, Hui Liu, Qi Li, Yan Wang, Bi-meng Zhang. Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis. Journal of Integrative Medicine, 2021, 19(2): 144-157.
[13] Nurul Afiedia Roslim, Aryati Ahmad, Mardiana Mansor, Myat Moe Thwe Aung, Farrahdilla Hamzah, Haszalina Hassan, Pei Lin Lua. Hypnotherapy for overweight and obese patients: A narrative review. Journal of Integrative Medicine, 2021, 19(1): 1-5.
[14] Johannes Loeser, Brigitte Layer, Christopher Plata, Klaus-Maria Perrar, Tim Hucho, Rebecca Kulbida. Hirudotherapy attenuates arthritic pain in patients with various chronic pain syndromes: A retrospective analysis. Journal of Integrative Medicine, 2020, 18(5): 425-433.
[15] Toktam Sadat Firoozeei, Majid Barekatain, Mehrdad Karimi, Arman Zargaran, Shahin Akhondzadeh, Hossein Rezaeizadeh. Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: A double-blind randomized trial. Journal of Integrative Medicine, 2020, 18(5): 409-415.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239